Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Molecular Profiles Associated With Resistance Development in Cancer Patients. Prospective Exploratory Study From 3 Cancer Locations: TNBC or Locally Advanced or Metastatic, Non-small Cell or Pancreatic or Bronchial Cancers

NCT04548960 is registered in ClinicalTrials.gov with Oncodesign SA as lead sponsor.

NCT NCT04548960
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04548960 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Molecular Profiles Associated With Resistance Development in Cancer Patients. Prospective Exploratory Study From 3 Cancer Locations: TNBC or Locally Advanced or Metastatic, Non-small Cell or Pancreatic or Bronchial Cancers
Lead sponsor
Oncodesign SA
Phase
Not applicable
Overall status
Unknown status
Start date
January 6, 2018
Completion date
March 31, 2023
Enrollment
600 (estimated)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

cancer